LobbyingPTC Therapeutics lobbying by quarter
PTC Therapeutics PTCT's latest lobbying report covers Q2 2026, at $270K. The four quarters Q4 2025–Q3 2026 total $1M. Its first report covers Q3 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
PTC TherapeuticsPTCT
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $1M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2022 | $190K | 1 |
| Q4 2022 | $290K | 4 |
| Q1 2023 | $710K | 5 |
| Q2 2023 | $310K | 5 |
| Q3 2023 | $280K | 5 |
| Q4 2023 | $280K | 5 |
| Q1 2024 | $550K | 3 |
| Q2 2024 | $140K | 3 |
| Q3 2024 | $140K | 3 |
| Q4 2024 | $130K | 3 |
| Q1 2025 | $260K | 3 |
| Q2 2025 | $200K | 3 |
| Q3 2025 | $240K | 3 |
| Q4 2025 | $240K | 3 |
| Q1 2026 | $490K | 3 |
| Q2 2026 | $270K | 3 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$2M · 46 reports
- Medicare and Medicaid$845.5K · 21 reports
- Taxation$830.5K · 20 reports
- Medical research and clinical labs$790.5K · 16 reports
- Budget and appropriations$116K · 4 reports
- Trade$112K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES47 reports
- SENATE47 reports
- Health & Human Services, Dept of (HHS)9 reports
- Centers For Medicare and Medicaid Services (CMS)8 reports
- Natl Institutes of Health (NIH)5 reports
- Executive Office of the President (EOP)2 reports
- Commerce, Dept of (DOC)1 reports
- Food & Drug Administration (FDA)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-housePTC Therapeutics | $3.4M | 16 quarters |
| BGR Government Affairs | $750K | 15 quarters |
| LMH Strategic Solutions | $230K | 5 quarters |
| Thorn Run Partners | $200K | 5 quarters |
| The McManus Group | $150K | 5 quarters |
| Taylor Strategies | $10K | 9 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| ALANNA TEMME | Legislative Director, U.S. Representative Jon Porter | Q2 2026 |
| BRENT ALAN DEL MONTE | See prior filing | Q2 2026 |
| DANIEL FARMER | Intern, Staff Asst, Leg. Corr./Leg. Asst. for Rep. Debbie Wasserman Schultz; Leg. Asst., Sr. Leg. Asst., Leg. Dir. for Zack Space | Q2 2026 |
| JOEL D. BAILEY | COS Rep. Panetta; LD Rep. Ashford; LD Rep. Matheson; Sr. LA Rep. Matsui; LA, Sr. LA Rep. Baron Hill; Intern Rep. Rahall | Q2 2026 |
| JOHN STONE | Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C | Q2 2026 |
| REMY LEIGH BRIM MASON | Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz | Q2 2026 |
| ROBB WALTON | Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Research Asst., Staff Asst., Intern on Senate HELP, Ranking Member, Sen. Enzi; Intern to Rep. Nunes | Q2 2026 |
| SOPHIE KHANAHMADI | Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions | Q2 2026 |
| RYAN LONG | Senior Policy and Counsel, Speaker Kevin McCarthy; Senior Policy Advisor and Counsel, Minority Leader Kevin McCarthy; Deputy Staff Director and Staff Director, House Energy and Commerce Committee; LC, Rep Norwood; LA & LD, Rep Barton | Q1 2025 |
| ALANNA TEMME | LD; Rep. Jon Porter | Q4 2023 |
| BEAU SCHUYLER | Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre | Q4 2023 |
| JOHN MCMANUS | Staff Director W&M Health Subcommittee; LA, Rep. Bill Thomas | Q4 2023 |
| STUART CHAPMAN | Chief of Staff, Representative Carolyn McCarthy; Chief of Staff, Representative Zack Space; Press Secretary, Senator Jay Rockefeller; Press Secretary, Representative Barbara Lee | Q4 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | BGR Government Affairs | $50K |
| 07/20for Q2 | In-house | $170K |
| 07/05for Q2 | LMH Strategic Solutions | $50K |
| 04/20for Q1 | BGR Government Affairs | $50K |
| 04/20for Q1 | In-house | $390K |
| 04/17for Q1 | LMH Strategic Solutions | $50K |
| 01/20for Q4 2025 | BGR Government Affairs | $50K |
| 01/20for Q4 2025 | In-house | $140K |
| 01/12for Q4 2025 | LMH Strategic Solutions | $50K |
| 25/10/20for Q3 2025 | BGR Government Affairs | $50K |
| 25/10/20for Q3 2025 | In-house | $140K |
| 25/10/20for Q3 2025 | LMH Strategic Solutions | $50K |
| 25/07/21for Q2 2025 | BGR Government Affairs | $50K |
| 25/07/21for Q2 2025 | In-house | $120K |
| 25/07/15for Q2 2025 | LMH Strategic Solutions | $30K |
| 25/05/08for Q2 2025 | LMH Strategic Solutions | Under $5,000 |
| 25/04/22for Q1 2023 | Taylor Strategies | $10K |
| 25/04/22for Q1 2025 | Taylor Strategies | Under $5,000 |
| 25/04/22for Q4 2024 | Taylor Strategies | Under $5,000 |
| 25/04/22for Q3 2024 | Taylor Strategies | Under $5,000 |